
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Operating Cash Flow 2011-2026 | ABMD
Annual Operating Cash Flow Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 275 M | 315 M | 252 M | 193 M | 115 M | - | - | - | 26.4 M | 3.63 M | 1.57 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 315 M | 1.57 M | 148 M |
Quarterly Operating Cash Flow Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 81.5 M | - | - | 206 M | 116 M | - | - | 188 M | 109 M | 31.8 M | - | 228 M | 139 M | 64.6 M | - | 182 M | 107 M | - | - | - | 36.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -33 K | - | - | 18.8 M | 11.1 M | - | - | -1.36 M | -6.29 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 228 M | -6.29 M | 88.9 M |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
602 M | $ 13.11 | - | $ 1.77 B | ||
|
BIOLASE
BIOL
|
-14.1 M | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
22.5 M | $ 10.66 | 2.7 % | $ 382 M | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
Second Sight Medical Products
EYES
|
-24.3 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
11.4 M | $ 25.93 | 0.27 % | $ 219 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.48 | 4.77 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
-44.8 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-10.4 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
-10.4 M | $ 2.13 | 4.41 % | $ 1.29 M | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-23.9 M | $ 11.2 | 0.18 % | $ 317 M | ||
|
Inspire Medical Systems
INSP
|
117 M | $ 56.2 | 0.15 % | $ 1.65 B | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
-12.4 M | $ 0.63 | 2.46 % | $ 39.2 M | ||
|
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M | ||
|
LivaNova PLC
LIVN
|
254 M | $ 60.38 | 0.46 % | $ 3.29 B | ||
|
IRIDEX Corporation
IRIX
|
-2.12 M | $ 1.04 | 0.97 % | $ 17.6 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-4.85 M | $ 15.15 | 0.6 % | $ 355 M | ||
|
Butterfly Network
BFLY
|
-41.7 M | $ 5.01 | 4.71 % | $ 1.06 B | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
753 M | $ 91.66 | 1.61 % | $ 12.4 B | ||
|
NanoVibronix
NAOV
|
-9.37 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
171 M | $ 36.75 | 0.11 % | $ 1.14 B | ||
|
Sintx Technologies
SINT
|
-8.57 M | $ 2.33 | 12.02 % | $ 6.46 M | ||
|
Integer Holdings Corporation
ITGR
|
196 M | $ 85.96 | -2.92 % | $ 2.99 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.6 B | $ 84.2 | 0.81 % | $ 49.2 B | ||
|
Stryker Corporation
SYK
|
5.04 B | $ 302.2 | -4.08 % | $ 116 B | ||
|
TransMedics Group
TMDX
|
193 M | $ 99.62 | -1.16 % | $ 3.39 B | ||
|
Tandem Diabetes Care
TNDM
|
-9.72 M | $ 19.85 | 1.66 % | $ 1.35 B | ||
|
LENSAR
LNSR
|
-14.8 M | $ 5.45 | 4.11 % | $ 65.2 M | ||
|
Pulmonx Corporation
LUNG
|
-32.4 M | $ 1.37 | 6.64 % | $ 55.7 M | ||
|
MiMedx Group
MDXG
|
74 M | $ 3.62 | 7.59 % | $ 535 M | ||
|
Myomo
MYO
|
-14.5 M | $ 0.89 | 3.01 % | $ 37.3 M |